{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,5,30]],"date-time":"2023-05-30T04:07:01Z","timestamp":1685419621156},"reference-count":17,"publisher":"National Library of Serbia","issue":"8","license":[{"start":{"date-parts":[[2011,1,1]],"date-time":"2011-01-01T00:00:00Z","timestamp":1293840000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-sa\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["VSP","VOJNOSANIT PREGL","VOJNOSANITETSKI PREG"],"published-print":{"date-parts":[[2011]]},"abstract":"<jats:p>Introduction. Systemic lupus erythematosus (SLE) is a chronic immunological\n   disease causing a significant morbidity and mortality in younger women and\n   involving several organs and systems, most often the kidneys, being\n   consequently the incidence of lupus nephritis (LN) about 60%. Case report. We\n   reported a 57 year-old patient with the diagnosed SLE in 1995.\n   Pathohistological analysis of kidney biopsy revealed LN type V. The patient\n   was treated with corticosteroid pulses and azathioprine during one year. A\n   remission was achieved and maintained with prednisone, 15 mg daily. Nephrotic\n   relapse was diagnosed in 2006 and the second kidney biopsy revealed recent\n   kidney infarction due to extensive vasculitis. Soon, a cerebrovascul insult\n   developed and CT-scan revealed endocranial infarctus. The patient was treated\n   with corticosteroids and cyclophosphamide pulses (totally VI monthly pulses),\n   and also with low-molecular heparine, anticoagulants and salicylates because\n   of the right leg phlebothrombosis. After the pulses, the patient was adviced\n   to take prednisone 20 mg daily and azothioprine 100 mg daily, and 6 months\n   later mycophenolate mofetil because of persistent active serological\n   immunological findings (ANA 1 : 320) and nephrotic syndrome. Mycophenolate\n   mofetil was efficient in inducing and maintaining remission of nephrotic\n   syndrome. Conclusion. The aim of LN treatment is to achieve and maintain\n   remission, improve patients? outcome, reduce the toxicity of\n   immunosuppressive drugs and the incidence of relapses. Mycophenolate mofetil\n   was shown to be efficient in inducing and maintaining remission of nephrotic\n   syndrome in the frame of LN.<\/jats:p>","DOI":"10.2298\/vsp1108705j","type":"journal-article","created":{"date-parts":[[2011,8,23]],"date-time":"2011-08-23T12:17:58Z","timestamp":1314101878000},"page":"705-708","source":"Crossref","is-referenced-by-count":0,"title":["A patient with systemic lupus erythematosus and lupus nephritis: A 12-year follow-up"],"prefix":"10.2298","volume":"68","author":[{"given":"Natasa","family":"Jovanovic","sequence":"first","affiliation":[{"name":"Klini\u010dki centar Srbije, Institut za urologiju i nefrologiju, Klinika za nefrologiju, Beograd"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jasmina","family":"Markovic-Lipkovski","sequence":"additional","affiliation":[{"name":"Medicinski fakultet, Institut za patologiju, Beograd"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stevan","family":"Pavlovic","sequence":"additional","affiliation":[{"name":"Klini\u010dki centar Srbije, Institut za urologiju i nefrologiju, Klinika za nefrologiju, Beograd"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Biljana","family":"Stojimirovic","sequence":"additional","affiliation":[{"name":"Klini\u010dki centar Srbije, Institut za urologiju i nefrologiju, Klinika za nefrologiju, Beograd"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1078","reference":[{"key":"1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(00)04239-2"},{"key":"2","doi-asserted-by":"publisher","DOI":"10.1007\/s00467-003-1278-y"},{"key":"3","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2006.04.008"},{"key":"4","doi-asserted-by":"publisher","DOI":"10.1191\/0961203305lu2057oa"},{"key":"5","doi-asserted-by":"publisher","DOI":"10.1016\/S0272-6386(00)70262-9"},{"key":"6","doi-asserted-by":"publisher","DOI":"10.1191\/0961203305lu2054oa"},{"key":"7","doi-asserted-by":"publisher","DOI":"10.1191\/0961203305lu2056oa"},{"key":"8","doi-asserted-by":"publisher","DOI":"10.1038\/sj.ki.5002118"},{"key":"9","doi-asserted-by":"publisher","DOI":"10.1191\/0961203305lu2055oa"},{"key":"10","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.03280807"},{"key":"11","doi-asserted-by":"publisher","DOI":"10.1191\/0961203305lu2059oa"},{"key":"12","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2006.09.002"},{"key":"13","doi-asserted-by":"publisher","DOI":"10.1191\/0961203305lu2060oa"},{"key":"14","doi-asserted-by":"publisher","DOI":"10.1191\/0961203305lu2081oa"},{"key":"15","doi-asserted-by":"publisher","DOI":"10.1191\/0961203305lu2061oa"},{"key":"16","doi-asserted-by":"publisher","DOI":"10.1186\/ar2093"},{"key":"17","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa031855"}],"container-title":["Vojnosanitetski pregled","Military Medical and Pharmaceutical Journal of Serbia"],"original-title":[],"language":"en","deposited":{"date-parts":[[2023,5,29]],"date-time":"2023-05-29T11:10:06Z","timestamp":1685358606000},"score":1,"resource":{"primary":{"URL":"https:\/\/doiserbia.nb.rs\/Article.aspx?ID=0042-84501108705J"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011]]},"references-count":17,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2011]]}},"URL":"https:\/\/doi.org\/10.2298\/vsp1108705j","relation":{},"ISSN":["0042-8450","2406-0720"],"issn-type":[{"value":"0042-8450","type":"print"},{"value":"2406-0720","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011]]}}}